Phase II study of talazoparib, a PARP inhibitor, in somatic BRCA1/2 mutant metastatic breast cancer identified by cell-free DNA or tumor tissue genotypingNeelima Vidula,Senthil Damodaran,Erica L. Blouch,Nora Horick,Nathan Royce Ruffle-Deignan,Manali Bhave,Ami N. Shah,Leticia Varella,Vandana Abramson,Joseph Sparano,Leif Ellisen,Ishraq Alim,Harry Ostrer,Hope Rugo,Aditya BardiaCANCER RESEARCH(2023)引用 0|浏览19暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要